JP Stock MarketDetailed Quotes

4519 Chugai Pharmaceutical

Watchlist
  • 6146.0
  • +179.0+3.00%
20min DelayMarket Closed Aug 9 14:59 JST
10.32TMarket Cap31.07P/E (Static)

Chugai Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
18.13%315.91B
-24.11%236.95B
-11.78%1.11T
-37.56%273.81B
14.48%257.9B
13.50%267.42B
-13.35%312.24B
26.00%1.26T
36.07%438.5B
-21.58%225.28B
Cost of revenue
-4.06%87.94B
-51.79%72.95B
-13.22%413.31B
-56.76%92.06B
13.26%78.26B
14.83%91.66B
32.25%151.33B
40.84%476.25B
92.58%212.91B
-33.69%69.1B
Gross profit
29.71%227.97B
1.92%164B
-10.90%698.06B
-19.43%181.75B
15.02%179.64B
12.82%175.76B
-34.57%160.91B
18.42%783.48B
6.55%225.59B
-14.68%156.19B
Operating expense
10.31%69.65B
2.41%64.13B
3.49%258.89B
-20.94%60.18B
23.02%72.96B
13.06%63.14B
6.30%62.62B
4.36%250.17B
4.77%76.11B
-2.65%59.3B
Selling and administrative expenses
-17.88%27.32B
7.47%22.59B
12.05%112.58B
0.02%30.76B
15.82%27.54B
43.65%33.26B
-7.77%21.02B
-1.89%100.48B
-11.73%30.75B
-3.77%23.78B
-Selling and marketing expense
-17.88%27.32B
7.47%22.59B
12.05%112.58B
0.02%30.76B
15.82%27.54B
43.65%33.26B
-7.77%21.02B
31.18%100.48B
26.32%30.75B
28.83%23.78B
Research and development costs
-3.66%42.94B
-3.53%41.36B
16.87%174.87B
-7.46%41.86B
24.15%45.57B
31.79%44.57B
26.58%42.87B
8.98%149.63B
19.64%45.23B
1.40%36.71B
Other operating expenses
95.90%-603M
114.59%185M
-44,726.56%-28.56B
-9,817.97%-12.44B
86.53%-160M
-1,203.82%-14.69B
-156.36%-1.27B
--64M
--128M
---1.19B
Operating profit
40.59%158.32B
1.60%99.87B
-17.65%439.17B
-18.66%121.58B
10.11%106.69B
12.68%112.62B
-47.44%98.3B
26.41%533.31B
7.49%149.47B
-20.69%96.89B
Net non-operating interest income (expenses)
-65.22%480M
-98.90%15M
51,733.33%4.65B
311.79%1.11B
142.48%788M
78.53%1.38B
-14.63%1.37B
-132.14%-9M
40.30%-526M
-667.28%-1.86B
Non-operating interest income
-65.44%480M
-98.90%15M
----
----
----
76.27%1.39B
-15.24%1.37B
----
----
----
Non-operating interest expense
----
----
-55.74%27M
-50.00%8M
-53.33%7M
-40.00%9M
-85.71%2M
27.08%61M
33.33%16M
25.00%15M
Total other finance cost
----
----
-8,888.46%-4.67B
-320.00%-1.12B
-143.21%-795M
----
----
31.58%-52M
-41.31%510M
642.77%1.84B
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
Other non-operating income (expenses)
15.98%-2.13B
3.09%267M
Income before tax
39.31%158.8B
0.23%99.89B
-16.44%443.82B
-17.78%122.69B
13.09%107.48B
13.19%113.99B
-46.48%99.66B
26.65%531.17B
7.78%149.22B
-20.60%95.03B
Income tax
52.40%46.94B
-2.57%25.49B
-24.49%118.35B
-32.64%31.48B
9.80%29.9B
8.70%30.8B
-51.94%26.16B
34.67%156.74B
18.03%46.74B
-19.12%27.24B
Net income
34.46%111.86B
1.23%74.4B
-13.08%325.47B
-11.00%91.21B
14.42%77.57B
14.94%83.19B
-44.22%73.5B
23.58%374.43B
3.68%102.48B
-21.18%67.8B
Net income continuous operations
34.46%111.86B
1.23%74.4B
-13.08%325.47B
-11.00%91.21B
14.42%77.57B
14.94%83.19B
-44.22%73.5B
23.58%374.43B
3.68%102.48B
-21.18%67.8B
Noncontrolling interests
Net income attributable to the company
34.46%111.86B
1.23%74.4B
-13.08%325.47B
-11.00%91.21B
14.42%77.57B
14.94%83.19B
-44.22%73.5B
23.58%374.43B
3.68%102.48B
-21.18%67.8B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
34.46%111.86B
1.23%74.4B
-13.08%325.47B
-11.00%91.21B
14.42%77.57B
14.94%83.19B
-44.22%73.5B
23.58%374.43B
3.68%102.48B
-21.18%67.8B
Gross dividend payment
Basic earnings per share
34.43%67.98
1.21%45.22
-13.10%197.83
-11.01%55.43
14.41%47.15
14.93%50.57
-44.25%44.68
23.52%227.64
3.61%62.29
-21.22%41.21
Diluted earnings per share
34.43%67.97
1.21%45.21
-13.08%197.8
-11.00%55.43
14.42%47.14
14.94%50.56
-44.23%44.67
23.57%227.57
3.66%62.28
-21.19%41.2
Dividend per share
2.50%41
0
2.56%80
0.00%40
0
5.26%40
0
2.63%78
-13.04%40
0
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 18.13%315.91B-24.11%236.95B-11.78%1.11T-37.56%273.81B14.48%257.9B13.50%267.42B-13.35%312.24B26.00%1.26T36.07%438.5B-21.58%225.28B
Cost of revenue -4.06%87.94B-51.79%72.95B-13.22%413.31B-56.76%92.06B13.26%78.26B14.83%91.66B32.25%151.33B40.84%476.25B92.58%212.91B-33.69%69.1B
Gross profit 29.71%227.97B1.92%164B-10.90%698.06B-19.43%181.75B15.02%179.64B12.82%175.76B-34.57%160.91B18.42%783.48B6.55%225.59B-14.68%156.19B
Operating expense 10.31%69.65B2.41%64.13B3.49%258.89B-20.94%60.18B23.02%72.96B13.06%63.14B6.30%62.62B4.36%250.17B4.77%76.11B-2.65%59.3B
Selling and administrative expenses -17.88%27.32B7.47%22.59B12.05%112.58B0.02%30.76B15.82%27.54B43.65%33.26B-7.77%21.02B-1.89%100.48B-11.73%30.75B-3.77%23.78B
-Selling and marketing expense -17.88%27.32B7.47%22.59B12.05%112.58B0.02%30.76B15.82%27.54B43.65%33.26B-7.77%21.02B31.18%100.48B26.32%30.75B28.83%23.78B
Research and development costs -3.66%42.94B-3.53%41.36B16.87%174.87B-7.46%41.86B24.15%45.57B31.79%44.57B26.58%42.87B8.98%149.63B19.64%45.23B1.40%36.71B
Other operating expenses 95.90%-603M114.59%185M-44,726.56%-28.56B-9,817.97%-12.44B86.53%-160M-1,203.82%-14.69B-156.36%-1.27B--64M--128M---1.19B
Operating profit 40.59%158.32B1.60%99.87B-17.65%439.17B-18.66%121.58B10.11%106.69B12.68%112.62B-47.44%98.3B26.41%533.31B7.49%149.47B-20.69%96.89B
Net non-operating interest income (expenses) -65.22%480M-98.90%15M51,733.33%4.65B311.79%1.11B142.48%788M78.53%1.38B-14.63%1.37B-132.14%-9M40.30%-526M-667.28%-1.86B
Non-operating interest income -65.44%480M-98.90%15M------------76.27%1.39B-15.24%1.37B------------
Non-operating interest expense ---------55.74%27M-50.00%8M-53.33%7M-40.00%9M-85.71%2M27.08%61M33.33%16M25.00%15M
Total other finance cost ---------8,888.46%-4.67B-320.00%-1.12B-143.21%-795M--------31.58%-52M-41.31%510M642.77%1.84B
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
Other non-operating income (expenses) 15.98%-2.13B3.09%267M
Income before tax 39.31%158.8B0.23%99.89B-16.44%443.82B-17.78%122.69B13.09%107.48B13.19%113.99B-46.48%99.66B26.65%531.17B7.78%149.22B-20.60%95.03B
Income tax 52.40%46.94B-2.57%25.49B-24.49%118.35B-32.64%31.48B9.80%29.9B8.70%30.8B-51.94%26.16B34.67%156.74B18.03%46.74B-19.12%27.24B
Net income 34.46%111.86B1.23%74.4B-13.08%325.47B-11.00%91.21B14.42%77.57B14.94%83.19B-44.22%73.5B23.58%374.43B3.68%102.48B-21.18%67.8B
Net income continuous operations 34.46%111.86B1.23%74.4B-13.08%325.47B-11.00%91.21B14.42%77.57B14.94%83.19B-44.22%73.5B23.58%374.43B3.68%102.48B-21.18%67.8B
Noncontrolling interests
Net income attributable to the company 34.46%111.86B1.23%74.4B-13.08%325.47B-11.00%91.21B14.42%77.57B14.94%83.19B-44.22%73.5B23.58%374.43B3.68%102.48B-21.18%67.8B
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders 34.46%111.86B1.23%74.4B-13.08%325.47B-11.00%91.21B14.42%77.57B14.94%83.19B-44.22%73.5B23.58%374.43B3.68%102.48B-21.18%67.8B
Gross dividend payment
Basic earnings per share 34.43%67.981.21%45.22-13.10%197.83-11.01%55.4314.41%47.1514.93%50.57-44.25%44.6823.52%227.643.61%62.29-21.22%41.21
Diluted earnings per share 34.43%67.971.21%45.21-13.08%197.8-11.00%55.4314.42%47.1414.94%50.56-44.23%44.6723.57%227.573.66%62.28-21.19%41.2
Dividend per share 2.50%4102.56%800.00%4005.26%4002.63%78-13.04%400
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
JP
Overall
Symbol
Latest Price
% Chg